Edrecolomab in the adjuvant treatment of colorectal carcinoma.
Spizzo
Gilbert
G
Obrist
Peter
P
Went
Philip
P
Dirnhofer
Stephan
S
Gastl
Günther
G
D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D015815:Cell Adhesion Molecules / Q000378:metabolism; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D015815:Cell Adhesion Molecules; C400149:Edrecolomab